CRISPR Therapeutics AG
업데이트됨

Safe Entry Zone CRSP

489
Price will Re-test Blue Line.

Blue Line act As Strong Support level now.


Note: 1- Potentional of Strong Buying Zone:

We have two scenarios must happen at The Mentioned Zone:

Scenarios One: strong buying volume with reversal Candle.
Scenarios Two: Fake Break-Out of The Buying Zone.

Both indicate buyers stepping in strongly. NEVER Join in unless one showed up.

2- How to Buy Stock (safe way):

On 1H TF when Marubozu/Doji Candle show up which indicate strong buyers stepping-in.
Buy on 0.5 Fibo Level of the Marubozu/Doji Candle, because price will always and always re-test the
노트
Red Zone is Final Target for this movement but it still yet far.
거래청산: 타겟 닿음
스냅샷
노트
Wait for Confirmation don't jump the market not stable these days. it seems to me like Bull Trap Despite all positive news going on.
노트
.05 Fibo entry
스냅샷
노트
3000 years later....
스냅샷
노트
i just want to prove a point that price re-test the .50 Fibo level most of time and its safest entry.

Major indices at major resistances I tend to not trade anything today sometimes and do different staff online.
노트
Just Last Update how it ended up with the close.
The Candle indicating Up movement by tomorrow "hopefully no sudden hazard news"
We Waited to re-test Line. Marubozu Candle to Show Up. then buy on 0.5 Fibo (usually my stop loss 2% very tight)
Cheers & Take Care !
스냅샷
노트
Now CRSP will target range of 40-60% profit to red zone (watch out for any selling pressure at Red Zone), have fun bye!
노트
for short term traders.
take profit line is dangerous zone.
스냅샷
노트
selling volume too high stop loss reached.
Major indices dragging stocks down since its all at major resistances.
노트
Insider was buying stocks equal of 51M $, which was behind the huge selling pressure and break of Blue Line.

Once inside Buy it means only one thing stock under-valued.(which is)

Now CRPS back to Up-Movement Strongly.

Personally I will Buy stock now once i see any pullback during session specially early hour.

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.